Login / Signup

Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.

Ellen BacklundMuyi YangVitali GrozmanGiuseppe V MasucciJohan FalkeniusHanna ErikssonBraslav JovanovicKatarina HammarlundUlf IsacssonCalin RaduEdvard AbelKristin KarlssonRicardo Palanco ZamoraPeter WersällUlrika EdbäckStina Linnea WickströmEva Darai RamqvistSuzanne Egyhazi BrageRolf KiesslingKristina ViktorssonBo FranzénRolf LewensohnRoger Olofsson BaggeGustav J UllenhagLars NyKarin LindbergHildur Helgadottir
Published in: Acta oncologica (Stockholm, Sweden) (2022)
Keyphrases
  • phase ii
  • open label
  • clinical trial
  • phase iii
  • double blind
  • phase ii study
  • study protocol
  • placebo controlled
  • cross sectional
  • radiation therapy